Albino Oliveira-Maia, psychiatrist, neuroscientist, and Director of the Neuropsychiatry Unit at the Champalimaud Foundation, has been elected to serve as President-Elect for the 2026–2029 term. He will subsequently assume the full presidency of the SPPSM from 2029 to 20321. Upon accepting the position, Oliveira-Maia emphasized the importance of advancing scientific progress and ensuring its real-world impact, stating: “Through leadership of this Society I hope to continue and expand on the work needed to make science and innovation accessible to those that most need it.”

For Leonor Beleza, Rui Costa’s arrival represents an invaluable contribution to the development of the Foundation’s scientific and clinical mission in the fields of cancer and neuroscience. She highlights: “The strategic vision and remarkable career of Professor Rui Costa strengthen our ability to generate knowledge and transform it into real benefits for patients and for society. It is also an investment in the future and in the continuity of our ambition and vision.”

TBC

Marta Moita, Behavioral Neuroscience Lab

TBC

Joaquim Alves da Silva, Neural Circuits Dysfunction Lab

Moderation

Rita Fior, Cancer Development and Innate Immune Evasion Lab

Venue

Champalimaud Foundation Auditorium 

Host

Michael Orger, PhD, Vision to Action Lab

Venue

Seminar room

Before there was a building by the river, before there were retreats and bustling labs, there was only an idea and a handful of conversations sparked across Lisbon, Boston, and New York.

When Tiago Santos first walked through the glass corridors of the Champalimaud Foundation (CF) in 2014, he already had two years of nursing experience, but none in urology or oncology. “Deep down, one could say I started a new chapter of my career here,” he admits with a wry smile. Indeed, stepping into a nearly empty unit with no reference guides, protocols, or precedents might have made most people run for the hills. But not Tiago. For him, the emptiness was an invitation: a white canvas on which to paint the future of urology nursing at CF.

The work fits into a broader effort to understand how the immune system maintains balance – a theme underscored by this year’s Nobel Prize in Physiology or Medicine for discoveries in immune tolerance.

When I interviewed Albino J. Oliveira-Maia, we spoke about the challenges and lessons that shaped his career. What struck me most was his ability to pursue different things at once and to create the space to keep doing so. By writing this, I hope to share that feeling of courage with others who are now wondering which path to follow.